KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy
Open Access
- 1 August 2006
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (8) , 828-836
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Homozygosity for human leucocyte antigen‐C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen‐C‐matched unrelated donor haematopoietic stem cell transplantationBritish Journal of Haematology, 2005
- Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and RéunionTissue Antigens, 2005
- Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemiasBlood, 2005
- Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive SuccessJournal of Experimental Medicine, 2004
- HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus InfectionScience, 2004
- The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHDTissue Antigens, 2004
- Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplantsBlood, 2002
- TCRγδ cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cellsBone Marrow Transplantation, 2001
- Development of a PCR‐SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoiresTissue Antigens, 2000
- Transplantation of Marrow from an Unrelated Donor to a Patient with Acute LeukemiaNew England Journal of Medicine, 1980